AI generated
Jun 21, 2026, 07:50
Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition
Pallavi Madhiraju, Owner of Cricket Herald, shared a post on LinkedIn:
“Discover whether Cure Gene’s evategrel can overcome clopidogrel variability and deliver rapid platelet inhibition without increasing bleeding risk.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 14:41Jens Helby: Long-Term Outcomes of Incidentally Detected Thrombocytopenia
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders